NCT05580081 is a NA clinical trial of i-CAN in Anxiety, sponsored by University of Alabama, Tuscaloosa.

Who is sponsoring NCT05580081?

NCT05580081 is sponsored by University of Alabama, Tuscaloosa.

What drugs are being tested in NCT05580081?

Interventions in NCT05580081: i-CAN.

What condition does NCT05580081 study?

NCT05580081 studies Anxiety, CBT.

Is NCT05580081 still recruiting?

NCT05580081 is currently completed. Last updated 3 April 2025.

Last reviewed 2025-04-03 · How we verify

NCT05580081

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optimizing CBT Implementation Among Community Providers Through Internet-based Consultation and Networking (i-CAN)

Completed NA Last updated 3 April 2025

What this trial tests

NA trial testing i-CAN in Anxiety in 100 participants. Completed in 1 February 2025.

Timeline

1 April 2023

Primary endpoint
1 December 2024

1 February 2025

Quick facts

Lead sponsor	University of Alabama, Tuscaloosa
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	100
Start date	1 April 2023
Primary completion	1 December 2024
Estimated completion	1 February 2025
Sites	1 location across United States

Drugs / interventions tested

i-CAN

Conditions studied

Anxiety — all drugs for Anxiety →
CBT — all drugs for CBT →

Sponsor

University of Alabama, Tuscaloosa

Who can join

18 and older, any sex, with Anxiety or CBT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although anxiety is one of the most common and debilitating mental health conditions affecting children and adolescents, the vast majority of sufferers do not receive effective treatment. Cognitive-behavioral therapy (CBT) is an evidence-based, frontline treatment for pediatric anxiety, yet many community-based practitioners do not implement CBT with high fidelity, which can detrimentally affect its clinical impact. The goal of this study is to develop and test an online platform to support community providers' effective use of CBT for pediatric anxiety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting

Other University of Alabama, Tuscaloosa trials

Trials by the same sponsor.

NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
NCT06864273 — Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama a · NA · recruiting
NCT05632575 — The Virtual Promotoras Study: eHealth Intervention to Promote Sexual Health Among Young Latina Women in the US South · NA · completed
NCT06076967 — Mindfulness Intervention for College Students With ADHD · NA · recruiting
NCT05820919 — Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05580081 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama, Tuscaloosa
Last refreshed: 3 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05580081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing